| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 17 |
| 1 | METHOTREXATE | 15 |
| 2 | ETANERCEPT | 10 |
| 3 | LAMIVUDINE | 8 |
| 4 | ASPIRIN | 7 |
| 5 | ASPIRIN 325 MG | 7 |
| 6 | ASPIRIN 81 MG | 7 |
| 7 | VALSARTAN | 7 |
| 8 | BARICITINIB | 6 |
| 9 | LAMIVUDINE ORAL | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BACILLUS CALMETTE-GUERIN | 5 | 0.0028 |
| 1 | GEMCITABINE INTRAVESICAL | 1 | 0.0021 |
| 2 | BARICITINIB | 6 | 0.0020 |
| 3 | UREA | 4 | 0.0018 |
| 4 | SILODOSIN | 4 | 0.0010 |
| 5 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 6 | CEFOXITIN SODIUM | 1 | 0.0007 |
| 7 | MITOMYCIN | 2 | 0.0005 |
| 8 | ENFORTUMAB VEDOTIN | 4 | 0.0005 |
| 9 | TERAZOSIN HYDROCHLORIDE | 4 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 5 | 0.0028 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 2 | Vitamin K [EPC] | 1 | 0.0001 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 | 0.0001 |
| 4 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 6 | 5-alpha Reductase Inhibitor [EPC] | 5 | 0.0000 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Androgen [EPC] | 1 | 0.0000 |